Aussie company picks up pace

Posted 9 July 2024 PM

Aussie biotech, Psylo, has joined forces with behavioural neuroscience expert Nick Everett to accelerate the development of their next-generation psychedelics that could enter clinical trials next year.

Everett, a research Fellow and NHMRC Emerging Leader at the University of Sydney's School of Psychology, has developed a machine-learning analysis technology which utilises high frame-rate cameras and sophisticated data-parsing techniques to predict the behavioural profiles and potential therapeutic properties of new drugs.

To see the whole article, please login